Stock listing
Transcode Therapeutics, Inc.
Selected listing: RNAZ · NASDAQ · USD · US
Transcode Therapeutics, Inc. (NASDAQ:RNAZ), Health Technology. Latest release Sep 28, 2026: TransCode Reports Continued Disease Stabilization and Extended…
- Ticker
- NASDAQ:RNAZ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. (Ticker: RNAZ) is a public company based in the United States, focusing on innovative therapeutic solutions. Transcode Therapeutics aims to address significant medical needs through its proprietary technologies.
Latest news from Transcode Therapeutics, Inc.
TransCode Reports Continued Disease Stabilization and Extended Treatment Duration with TTX-MC138 in Ongoing Phase 1a Clinical Trial Follow-Up
September 28, 2026
TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology
September 22, 2026
TransCode Therapeutics Announces Leadership Transition
September 10, 2026
TransCode Therapeutics Announces Publication Demonstrating Survival Benefit of TTX-MC138 in Preclinical Model of Breast Cancer Bone Metastasis
August 31, 2026
TransCode Therapeutics to Host R&D Webcast on June 18, 2026
June 8, 2026
Research Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. company profile
View the public company page for Transcode Therapeutics, Inc. on 6ix.
Transcode Therapeutics, Inc. news
Read company news and market updates connected to Transcode Therapeutics, Inc..
Transcode Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Transcode Therapeutics, Inc..